Identification of a novel secretogranin II-derived peptide (SgII (187-152)) in adult and fetal human adrenal glands using antibodies raised against the human recombinant peptide, J Clin Endocrinol Metab, vol.83, pp.2944-2951, 1998. ,
Biochemical characterization and immunocytochemical localization of EM66, a novel peptide derived from secretogranin II, in the rat pituitary and adrenal glands, J Histochem Cytochem, vol.51, pp.1083-1095, 2003. ,
URL : https://hal.archives-ouvertes.fr/hal-01706425
Identification of the secretogranin II-derived peptide EM66 in pheochromocytomas as a potential marker for discriminating benign versus malignant tumors, J Clin Endocrinol Metab, vol.88, pp.2579-2585, 2003. ,
URL : https://hal.archives-ouvertes.fr/hal-01706414
Immunohistochemical distribution of the secretogranin II-derived peptide EM66 in the rat hypothalamus: A comparative study with jerboa, Neuroscience Lett, vol.414, pp.268-272, 2007. ,
URL : https://hal.archives-ouvertes.fr/hal-01706443
Chromogranins A and B and secretogranin II: evolutionary and functional aspects, Acta Physiol. (Oxf ), vol.192, pp.309-324, 2008. ,
URL : https://hal.archives-ouvertes.fr/hal-02334366
Biochemical characterisation and immunohistochemical localization of the secretogranin II-derived peptide EM66 in the hypothalamus of the jerboa (Jaculus orientalis): modulation by food deprivation, J Neuroendocrinol, vol.17, pp.372-378, 2005. ,
Stress responsiveness of hypothalamic corticotropin-releasing factor and pituitary pro-opiomelanocortin mRNAs following high-dose glucocorticoid treatment and withdrawal in the rat, J Endocrinol, vol.127, pp.407-415, 1990. ,
Regulatory changes in neuroendocrine stress-integrative circuitry produced by a variable stress paradigm, Neuroendocrinology, vol.61, pp.180-190, 1995. ,
CRH and the immune system, J Neuroimmunol, vol.72, pp.131-136, 1997. ,
Increased expression of corticotropin-releasing hormone and vasopressin messenger ribonucleic acid (mRNA) in the hypothalamic paraventricular nucleus during repeated stress: association with reduction in glucocorticoid receptor mRNA levels, Endocrinology, vol.136, pp.3299-3309, 1995. ,
CCK mRNA expression in neuroendocrine CRH neurons is increased in rats subjected to an immune challenge, Brain Res, vol.901, pp.277-280, 2001. ,
Immunocytochemical detection of CCK and CRH neuropeptides in the hypothalamic paraventricular nucleus of the jerboa (Jaculus orientalis): modulation by immobilization stress, J Neuroendocrinol, vol.18, pp.767-775, 2006. ,
How the blood talks to the brain parenchyma and the paraventricular nucleus of the hypothalamus during systemic inflammatory and infectious stimuli, Proc Soc Exp Biol Med, vol.223, pp.22-38, 2000. ,
Interleukin-1 stimulates the secretion of hypothalamic corticotropinreleasing factor, Science, vol.238, pp.522-524, 1987. ,
Behavioural effects of preferentially injected interleukin-1: role of prostaglandins, Brain Res, vol.542, pp.330-335, 1991. ,
The effects of recombinant human interleukin (IL)-1?, IL-1? or IL-6 on hypothalamo-pituitary-adrenal axis activation, J Endocrinol, vol.133, pp.349-355, 1992. ,
A functional anatomical analysis of central pathways subserving the effects of interleukin-1 on stress-related neuroendocrine neurons, J Neurosci, vol.14, pp.897-913, 1994. ,
Activation of the hypothalamus-pituitary-adrenal axis by bacterial endotoxins: routes and intermediate signals, Psychoneuroendocrinology, vol.19, pp.209-232, 1994. ,
Influence of cytokines on neuroendocrine functions during immune response. Mechanisms involved and neuronal pathways, Ann Endocrinol, vol.56, pp.159-167, 1995. ,
The Rat Brain in Stereotaxic Coordinates, p.21, 1986. ,
The glucose-oxidase DAB-nickel method in peroxydase histochemistry of the nervous system, Neurosci Lett, vol.85, pp.169-171, 1988. ,
Regulation of corticotropic function in stressful situations, Ann Endocrinol, vol.56, pp.245-251, 1995. ,
Neurocircuitry of stress: central control of hypothalamo-pituitary-adrenocortical axis, Trends Neurosci, vol.20, pp.78-84, 1997. ,
Multiple mechanisms of cytokine action in neurodegenerative and psychiatric states: neurochemical and molecular substrates, Curr Pharm Des, vol.11, pp.947-962, 2005. ,
Interferon-? effects are exaggerated when administered on a psychosocial stressor backdrop: cytokine, corticosterone and brain monoamine variations, J Neuroimmunol, vol.186, pp.45-53, 2007. ,
Repeated stress-induced activation of corticotropin-releasing factor neurons enhances vasopressin stores and colocalization with corticotropin-releasing factor in the median eminence of rats, Neuroendocrinology, vol.53, pp.150-159, 1991. ,
Repeated stress enhances vasopressin synthesis in corticotropin releasing factor neurons in the paraventricular nucleus, Brain Res, vol.577, pp.165-168, 1992. ,
Fos expression variances in mouse hypothalamus upon physical and osmotic stimuli: co-staining with vasopressin, oxytocin, and tyrosine hydroxylase, Brain Res Bull, vol.5, pp.423-431, 2005. ,
Mechanisms of CNS response to systemic immune challenge: the febrile response, Trends Neurosci, vol.20, pp.565-570, 1997. ,
Subdiaphragmatic vagotomy blocks interleukin-1beta-induced fever but does not reduce IL-1beta levels in the circulation, Auton Neurosci, vol.85, pp.72-77, 2000. ,
Cytokine-to-brain communication: a review & analysis of alternative mechanisms, Life Sci, vol.57, pp.1011-1026, 1995. ,
Vagotomy attenuates behavioural effects of interleukin-1 injected peripherally but not centrally, Neuroreport, vol.7, pp.1485-1488, 1996. ,
Suppression of splenic macrophage interleukin-1 secretion following intracerebroventricular injection of interleukin-1?: evidence for pituitary-adrenal and sympathetic control, Cell Immunol, vol.132, pp.84-93, 1991. ,
?-MSH and ?-MSH inhibit IL-1? induced activation of the hypothalamic-pituitary-adrenal axis through central melanocortin receptors, Regul Pept, vol.122, pp.185-190, 2004. ,